Oramed Pharmaceuticals (ORMP) Prepaid Assets (2011 - 2026)

Oramed Pharmaceuticals has reported Prepaid Assets for 16 years, with the latest figure at $2.3 million in Q1 2026.

• For the quarter ending Q1 2026, Prepaid Assets rose 177.64% year-over-year to $2.3 million; the trailing twelve-month figure through Mar 2026 stood at $2.3 million (up 177.64% YoY), and the FY2025 full-year result was $2.7 million, up 112.32% from the prior year.
• Prepaid Assets for Q1 2026 stood at $2.3 million, down from $2.7 million in the prior quarter.
• The five-year high for Prepaid Assets was $2.7 million in Q4 2025, with the low at $474000.0 in Q3 2024.
• Historically, Prepaid Assets has averaged $1.1 million across 5 years, with a median of $958000.0 in 2022.
• Annual changes were most pronounced in 2024 — Prepaid Assets slumped 64.79% — and 2025, when it jumped 201.69%.
• Oramed Pharmaceuticals' Prepaid Assets stood at $1.4 million in 2022, then plunged by 61.34% to $537000.0 in 2023, then soared by 140.41% to $1.3 million in 2024, then soared by 112.32% to $2.7 million in 2025, then decreased by 15.72% to $2.3 million in 2026.
• The last three Prepaid Assets figures came in at $2.3 million (Q1 2026), $2.7 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.